|
CRYAB
|
Associated with poor prognosis and metastasis, negative regulator of TRAIL-mediated apoptosis, related to hypoxic survival and metastasis
|
Several
|
[101–103]
|
|
TACSTD2
|
Correlated with malignant progression, apoptosis resistance and proliferation
|
Cervical
|
[104–106]
|
|
BCL-3
|
Negative regulator of apoptosis
|
Several
|
[107, 108]
|
|
COX19
|
Biogenesis and regulation of mitochondrial respiratory homeostasis
|
Several
|
[109, 110]
|
|
OASL
|
Displays antiviral activity, responsive to type I interferon signal
|
Several
|
[111, 112]
|
|
CDKN2A
|
Overexpression is used as a biomarker for progressing lesions
|
Cervical
|
[113]
|
|
NIBAN/FAM129A
|
Anti-apoptotic activity
|
Several
|
[114–116]
|
|
FST
|
Attenuates rRNA synthesis and trigger FST-mediated apoptosis
|
Cervical, Breast
|
[117, 118]
|
